Literature DB >> 33085242

[Expression of fibroblast growth factor receptor like 1 protein in oral squamous cell carcinoma and its influence on tumor cell proliferation and migration].

Chen Zheng1, Chao-Ji Shi2, Lin-Juan Du2, Yin-Hua Jiang3, Ji-Mei Su1.   

Abstract

OBJECTIVE: This study aims to investigate the expression of fibroblast growth factor receptor like 1 (FGFRL1) in oral squamous cell carcinoma (OSCC) and reveals its association with tumor cell proliferation and migration.
METHODS: Western blot was performed to detect the expression of FGFRL1 protein in OSCC tissues, adjacent normal tissues, OSCC cell lines and normal epithelial cells. After knocking down of FGFRL1 in HN4 cells, CCK-8 and Ki67 assays were performed to detect cell proliferation, wounding healing assay and transwell were performed to detect cell-migration. Western blot was used to detect the expression of protein related to epithelial-mesenchymal transition (EMT).
RESULTS: The expression of FGFRL1 in OSCC tissues was higher than that in adjacent nontumor tissues, respectively (t=2.820, P=0.047 8). Moreover, the expression of FGFRL1 in OSCC cells was higher than that in HOK cells. Quantitative real-time polymerase chain reaction (qRT-PCR) showed that FGFRL1 expression of FGFRL1 RNA in HOK cells was lower than that in OSCC cells. HN4 cells transfected with FGFRL1 siRNA were included in the experimental group, whereas HN4 cells treated with NC siRNA were included in the control group. CCK-8 experiment showed no significant difference between the experimental and control groups with regard to proliferation ability at 48 h (P=0.478 1) and 72 h (P=0.334 2). Migration experiment showed that the wound healing areas in the experimental group after 12 h (P=0.022 8), 24 h (P=0.005 1), and 36 h (P=0.009 5)were smaller than that in the control group. Transwell invasion assay showed that the number of invaded cells in the experimental group after 16 h (P=0.008 7) and 24 h (P=0.008 6) were lower than that in the control group. Knocking-down FGFRL1 up-regulated the expression of E-cadherin and down-regulated the expression of N-cadherin and Vimentin in HN4 cells.
CONCLUSIONS: FGFRL1 expression in the OSCC tissues was significantly higher than that in the adjacent nontumor tissues. FGFRL1 expression in the OSCC cells was significantly higher than that in the HOK cells, and FGFRL1 had no effect on cell proliferation but promoted tumor cell migration and EMT.

Entities:  

Keywords:  RNA interference; cell migration; epithelial-mesenchymal transition; fibroblast growth factor receptor like 1; oral squamous cell carcinoma

Mesh:

Substances:

Year:  2020        PMID: 33085242      PMCID: PMC7573774          DOI: 10.7518/hxkq.2020.05.015

Source DB:  PubMed          Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi        ISSN: 1000-1182


  28 in total

Review 1.  Head and neck cancer.

Authors:  A Forastiere; W Koch; A Trotti; D Sidransky
Journal:  N Engl J Med       Date:  2001-12-27       Impact factor: 91.245

2.  Rapid fusion and syncytium formation of heterologous cells upon expression of the FGFRL1 receptor.

Authors:  Florian Steinberg; Simon D Gerber; Thorsten Rieckmann; Beat Trueb
Journal:  J Biol Chem       Date:  2010-09-17       Impact factor: 5.157

3.  Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization.

Authors:  Omar A Ibrahimi; Brian K Yeh; Anna V Eliseenkova; Fuming Zhang; Shaun K Olsen; Makoto Igarashi; Stuart A Aaronson; Robert J Linhardt; Moosa Mohammadi
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

Review 4.  [The role of microRNA-210 in esophageal squamous cell carcinoma].

Authors:  Soken Tsuchiya
Journal:  Yakugaku Zasshi       Date:  2012       Impact factor: 0.302

5.  Aberrant expression of FGFRL1, a novel FGF receptor, in ovarian tumors.

Authors:  Christof Schild; Beat Trueb
Journal:  Int J Mol Med       Date:  2005-12       Impact factor: 4.101

Review 6.  Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer.

Authors:  Geert Berx; Eric Raspé; Gerhard Christofori; Jean Paul Thiery; Jonathan P Sleeman
Journal:  Clin Exp Metastasis       Date:  2007-11-03       Impact factor: 5.150

7.  Expression of FGFRL1, a novel fibroblast growth factor receptor, during embryonic development.

Authors:  Beat Trueb; Sara Taeschler
Journal:  Int J Mol Med       Date:  2006-04       Impact factor: 4.101

8.  Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters.

Authors:  Junlin Li; Binhua P Zhou
Journal:  BMC Cancer       Date:  2011-02-01       Impact factor: 4.430

9.  Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation.

Authors:  Ching-Yi Liu; Hsi-Hui Lin; Ming-Jer Tang; Yang-Kao Wang
Journal:  Oncotarget       Date:  2015-06-30

10.  FGFRL1 deficiency reduces motility and tumorigenic potential of cells derived from oesophageal squamous cell carcinomas.

Authors:  Yoshinori Takei; Takafumi Matsumura; Kazuaki Watanabe; Hirokazu Nakamine; Tetsuo Sudo; Kazuharu Shimizu; Yutaka Shimada
Journal:  Oncol Lett       Date:  2018-05-18       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.